Disclaimer: This site analyses public FDA records. It is not medical advice. If you feel unwell, contact a healthcare professional immediately.
Supplement Safety Checker
Notice: Official Public Record

Genetic Edge Compounds LLC FDA Warning (2017)

Compiled by the Supplement Safety Data Team | Sourced from Official FDA Records on April 14, 2017

HIGH SEVERITY Dallas District Office 2017
Disclaimer: This report is an analysis of a public FDA warning letter. It is not medical advice. If you have consumed these products and feel unwell, contact a healthcare professional immediately.

Executive Summary

The FDA issued a warning letter to Genetic Edge Compounds LLC on April 14, 2017 citing regulatory violations. Consumers who have purchased products from this company should exercise caution. The letter was issued by Dallas District Office.

Regulatory Violations

Detailed Analysis

False Claims and Regulatory Violations

“Milk thistle – used as a natural treatment for liver problems….helps repair liver cells damaged by alcohol and other toxic substances.”

“Alpha Lipoic Acid…may also be helpful in certain liver diseases.”

“Chinese skullcap…helpful in preventing heart disease and limiting the damage to the heart following a heart attack. It is also used to combat high cholesterol, triglycerides, and high blood pressure.”

Potential Health Risks

“[D]ecreases the amount of testosterone in men putting them at risk for many unwanted side effects such as depression… “

Ensure that a qualified person will investigate any product complaint that involves a possible failure of a dietary supplement to meet any of its specifications, or any other requirements of 21 CFR 111, including those specifications and other requirements that, if not met, may result in a risk of illness or injury [21 CFR 111.560(a)(2)].

Regulatory Context

Be held using the same container-closure system in which the packaged and labeled dietary supplements were distributed [21 CFR 111.83(b)(1)].

Be identified with the appropriate batch, lot, or control number [21 CFR 111.83(b)(2)].

Be retained for one year past the shelf life date (if shelf life dating is used), or for two years from the date of distribution of the last batch of dietary supplement associated with the reserve sample [21 CFR 111.83(b)(3)].

Key Entities Identified

21 CFR 111.83 21 CFR 111.83 21 CFR 111.83

Frequently Asked Questions

What did the FDA find wrong with Genetic Edge Compounds LLC?
The FDA issued a warning letter citing regulatory violations related to their products or manufacturing practices.
Are Genetic Edge Compounds LLC products safe to use?
Based on the FDA's findings, consumers should exercise caution. The company was found to have regulatory issues that may affect product safety.
What should I do if I've used Genetic Edge Compounds LLC products?
If you have used products from Genetic Edge Compounds LLC and experience any adverse effects, contact your healthcare provider immediately. You can also report adverse events to the FDA's MedWatch program.

Source Document

This report is based on an official FDA warning letter. The original document is a public record.

View Original FDA Warning Letter
Medical Disclaimer: This report is an analysis of public FDA warning letters. It is not medical advice. If you have consumed these products and feel unwell, contact a healthcare professional immediately. You can report adverse events to the FDA MedWatch program.